Ethanol acts on KCNK13 potassium channels in the ventral tegmental area to increase firing rate and modulate binge-like drinking, Neuropharmacology (2018), doi: https://doi.org/10. 1016/ j.neuropharm.2018.10.008. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Therefore two-pore potassium channels in the VTA may be potential targets for the action of ethanol. Here, we explored whether ethanol activation of VTA neurons is mediated by the twopore potassium channel KCNK13. Extracellular recordings of the response of VTA neurons to ethanol were performed in combination with knockdown of Kcnk13 using a short hairpin RNA (shRNA) in C57BL/6J mice. Real-time PCR and immunohistochemistry were used to examine expression of this channel in the VTA. Finally, the role of KCNK13 in binge-like drinking was examined in the drinking in the dark test after knockdown of the channel. Kcnk13 expression in the VTA was increased by acute ethanol exposure. Ethanol-induced excitation of VTA neurons was selectively reduced by shRNA targeting Kcnk13. Importantly, knockdown of Kcnk13 in the VTA resulted in increased alcohol drinking. These results are consistent with the idea that ethanol stimulates VTA neurons at least in part by inhibiting KCNK13, a specific two-pore potassium channel, and that KCNK13 can control both VTA neuronal activity and binge drinking. KCNK13 is a novel alcohol-sensitive molecular target and may be amenable to the development of pharmacotherapies for alcoholism treatment.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT

Abstract:
Alcohol excitation of the ventral tegmental area (VTA) is important in neurobiological processes related to the development of alcoholism. The ionotropic receptors on VTA neurons that mediate ethanol-induced excitation have not been identified. Quinidine blocks ethanol excitation of VTA neurons, and blockade of two-pore potassium channels is among the actions of quinidine.
Therefore two-pore potassium channels in the VTA may be potential targets for the action of ethanol. Here, we explored whether ethanol activation of VTA neurons is mediated by the twopore potassium channel KCNK13. Extracellular recordings of the response of VTA neurons to ethanol were performed in combination with knockdown of Kcnk13 using a short hairpin RNA (shRNA) in C57BL/6J mice. Real-time PCR and immunohistochemistry were used to examine expression of this channel in the VTA. Finally, the role of KCNK13 in binge-like drinking was examined in the drinking in the dark test after knockdown of the channel. Kcnk13 expression in the VTA was increased by acute ethanol exposure. Ethanol-induced excitation of VTA neurons was selectively reduced by shRNA targeting Kcnk13. Importantly, knockdown of Kcnk13 in the VTA resulted in increased alcohol drinking. These results are consistent with the idea that ethanol stimulates VTA neurons at least in part by inhibiting KCNK13, a specific two-pore potassium channel, and that KCNK13 can control both VTA neuronal activity and binge drinking. KCNK13 is a novel alcohol-sensitive molecular target and may be amenable to the development of pharmacotherapies for alcoholism treatment.
Introduction
Activation of dopaminergic (DA) neurons of the ventral tegmental area (VTA) is a property of alcohol that is important for its rewarding and reinforcing actions (Koob and Volkow, 2010) .
VTA neuronal activity is subject to regulation by several different ionic currents (Canavier et al., 2007; Korotkova et al., 2004) and by synaptic activity, especially activity related to γ-aminobutyric acid (GABA) (Guan et al., 2012; Theile et al., 2011) or glutamate (Deng et al., 2009; Xiao et al., 2009 ) neurotransmission. However, acutely dissociated neurons devoid of synaptic connections are still activated by ethanol, indicating that ethanol can excite VTA neurons independent of extrinsic afferents (Brodie et al., 1999) . Furthermore, our recent comparison of toluene and ethanol excitation of VTA neurons demonstrated that the effect of ethanol is not diminished by combinations of antagonists of GABA A , GABA B , NMDA, AMPA, metabotropic glutamate, muscarinic and nicotinic cholinergic receptors (Nimitvilai et al., 2016) , indicating that these receptors, although important for modulating ethanol excitation, are not primary mediators of the excitatory action of ethanol on VTA neurons in vitro. Several ion channels present on VTA neurons, e.g. h-channels (HCN) (Okamoto et al., 2006; Rivera-Meza et al., 2014) and G protein-coupled potassium channels (GIRK) (Herman et al., 2015) , have been suggested as targets of ethanol in the VTA, but pharmacological antagonists of these channels do not reduce ethanol excitation in the VTA (Appel et al., 2003; Koyama et al., 2007; McDaid et al., 2008) , so their role in ethanol excitation is likely to be subordinate to a different mechanism that is primarily responsible for the excitation.
One class of ion channels that has been neglected with respect to studies of alcohol is the large family of two-pore channels often called leak potassium channels. These channels are constitutively open and help maintain a negative resting membrane potential (Goldstein et al., 
). Modulation of leak channel conductance could effectively regulate neuronal activity; specifically, inhibition of leak channels would produce excitation. Depolarization and increased spontaneous firing of VTA neurons, therefore, might occur if ethanol inhibited a leak potassium channel. Different two-pore channels have diverse pharmacological profiles; for example, some are activated by volatile anesthetics and others are inhibited by those same anesthetics (Enyedi and Czirjak, 2010) . The tandem-pore halothane-inhibited potassium (THIK) channels, KCNK12 and KCNK13, are inhibited by isoflurane, halothane, quinine, quinidine, and by high extracellular calcium concentration (Enyedi and Czirjak, 2010) . These channels are expressed in many brain areas (Rajan et al., 2001 ), but there are few reports characterizing the function of THIK channels in the central nervous system. As ethanol excitation is blocked by quinidine (Appel et al., 2003) and quinine (Nimitvilai et al., 2016) , we hypothesized that THIK leak potassium channels play an important role in mediation of ethanol excitation of VTA neurons. If ethanol action on leak potassium channels in the VTA is behaviorally important, then interfering with this target should alter alcohol drinking. Here, we provide evidence that one THIK channel, KCNK13, affects ethanol excitation and regulates binge-like ethanol consumption. KNCNK13 may be a novel and significant target of ethanol action on VTA neurons.
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4 pharmacologically as dopamine-containing neurons (Margolis et al., 2006; Margolis et al., 2012) , but all of the neurons conforming to these electrophysiological criteria that have been tested with baclofen (0.1-1 µM) in our laboratory have been inhibited; sensitivity to inhibition by baclofen is a property of DA VTA neurons but not GABAergic VTA neurons (Margolis et al., 2012) . The VTA neurons in this study (32 cells from 14 mice) had a mean firing rate of 2.28 ± 0.16 Hz with a mean interspike interval of 0.54 ± 0.05 msec. The mean coefficient of variation (CV) for the cells reported below was 0.13 ± 0.02. Note that a low CV does not distinguish between DA and non-DA neurons (Margolis et al., 2012) .
Drugs were added to the aCSF using a calibrated infusion pump from stock solutions 100 to 1000 times the desired final concentrations. Final concentrations were calculated from aCSF flow rate, pump infusion rate and concentration of drug stock solution. The small volume chamber (about 300 µl) used in these studies permitted the rapid application and washout of drug solutions. Ethanol (95%; 190 proof) and most of the salts used to prepare the extracellular media were purchased from Sigma (St. Louis, MO). Isoflurane was from Henry Schein Animal Health (Dublin, OH). Extracellular recording electrodes were made from 1.5 mm diameter glass tubing (Sutter Instruments, Novato, CA) with filament and were filled with 0.9% NaCl. Tip resistance of all microelectrodes ranged from 2 -4 MΩ. A high-gain extracellular amplifier (x-Cell, FHC, Inc., Bowdoin, ME) was used in conjunction with an IBM-PC-based data acquisition system (ADInstruments, Inc.). Firing rate was determined before and during drug application, and was calculated over one minute intervals prior to administration of drugs and during the drug effects.
The change in firing rate is expressed as a percentage of the initial firing rate, which controls for slight changes in firing rate that may occur over time. Three different shRNAs were designed to target mouse Kcnk13 using the siDirect 2.0 design tool (Naito and Ui-Tei, 2012) . The three 21-nucleotide targeting sequences were incorporated into hairpins and the oligonucleotides cloned into the lentiviral vector pLL3.7 (Lasek et al., 2007) .
The control shRNA (shScr) sequence has been described previously and encodes a nonspecific hairpin, predicted to not target any gene in the mouse genome. Sequences and in vitro testing of the Kcnk13 shRNA are shown in Supplementary Fig S1. Lentivirus was produced in 293FT cells as previously described (Dutton et al., 2016) .
Stereotaxic surgery and lentiviral injections
Mice were anesthetized with ketamine/xylazine, placed in a stereotaxic alignment system (David Kopf Instruments) and injected with 1.0 µl of virus solution bilaterally. VTA coordinates were: AP −3.2 mm, ML +/− 0.5 mm, DV −4.7 mm. Viral titers were 3 × 10 7 pg p24 gag antigen/ml.
Mice recovered for 3 weeks prior to testing ethanol consumption or electrophysiological studies.
Viral infection was confirmed by immunohistochemistry after the completion of drinking in the dark (DID) testing using anti-GFP and anti-TH antibodies (see Figure 3C small image for example).
Immunofluorescent staining of brain sections
Mice were euthanized with pentobarbital followed by transcardial perfusion with cold phosphate-buffered saline (PBS) and 4% paraformaldehyde. Brains were processed as described previously (Kharazia et al., 2003) . Primary antibodies for TH and KCNK13 detection (Fig 1) were mouse anti-TH (EMD Millipore, Burlington, MA, catalog number MAB318) and rabbit anti-KCNK13 (Novus, Littleton, CO, catalog number NBP2-41132). Primary antibodies for GFP M A N U S C R I P T A C C E P T E D For quantification of knockdown of KCNK13 in the VTA after lentiviral infection, the intensity of KCNK13 staining in the infected VTA was quantified from 2-10 cells (GFP+, and GFP-) per section, 3 sections per mouse and 5-6 mice per group (shScr and shKcnk13) 3 weeks after lentiviral infection. Intensity of KCNK13 immunofluorescence was measured using the National
Institutes of Health ImageJ software, and compared between GFP+ and GFP-cells. As comparisons were made between GFP+ and GFP-cells in each slice, a paired t-test was used to establish statistical significance for differences between the groups.
Drinking in the dark (DID)
The 4-day ethanol drinking test was a two-bottle variation of the standard DID test as described previously (Rhodes et al., 2005) . Briefly, mice were individually housed in a 12-hour reversed light/dark cycle room (lights off 10 am to 10 pm) for 2 weeks prior to behavioral testing. The DID test was performed by replacing the water bottle 3 hours into the dark cycle with a pair of sipper tubes, one containing water and the other containing 20% ethanol in water. Locations of the alcohol and water tubes were alternated daily. On the first 3 days of each week (day 1, 2, 3
and day 8, 9, 10), mice were given access to the ethanol solution for 2 hours. On the fourth day
of each week (day 4 and day 11), mice were given access to the ethanol solution for 4 hours. We did not test at the two hour time point on days 4 and 11, as we were concerned that disruption at the two hour time point would alter drinking over the 4 hour session in the groups differentially.
Mice had no access to alcohol on Days 5, 6 and 7. Blood samples (20 µl) were collected immediately after the 4-hour drinking session on day 11 to measure blood ethanol concentrations (BECs). Blood was collected in heparinized capillary tubes via tail vein puncture. BECs were determined using a nicotinamide adenine dinucleotide-alcohol dehydrogenase enzymatic assay (Zapata et al., 2006) . To test sucrose consumption, mice underwent a test identical to the ethanol consumption test, except one of the provided sipper tubes contained 2% sucrose instead of 20%
ethanol.
Quantitative real-time PCR (qPCR)
Mice were sacrificed one or four hour(s) after intraperitoneal injection of 3g/kg ethanol or saline.
Brains were rapidly harvested after sacrifice, and the VTA was dissected using RNase-free conditions. RNA was isolated from VTA tissue using the RNeasy mini kit (Qiagen, Valencia, CA) and subjected to first strand cDNA synthesis using reverse transcriptase (Thermo Fisher, Waltham, MA). Quantitative real-time PCR was used to determine the mRNA level of Kcnk13.
Relative expression was calculated using the delta Cq method. Details of the methods used for qPCR to examine the mRNA expression of Kcnk13 in the VTA after acute ethanol exposure is provided in Supplementary Information. The results are expressed as fold change in reference to Gapdh expression.
Statistical Analysis
Statistical analyses were performed with Origin (Originlab, Northampton, MA) or GraphPad Prism version 6.05 (GraphPad Software, Inc., La Jolla, CA). Comparison of differences in baseline firing rate ( Figure 1A , 4C), and differences in protein expression ( Figure 3B ), were assessed with paired t tests (within subjects); differences in mRNA expression (Figure 2B and 3A) and BECs ( Figure 5C ) were assessed with unpaired t tests (between subjects). One-way ANOVA was used to assess significance of excitation induced by isoflurane ( Figure 1B ) and 4-hour drinking ( Figure 5B ). Two-way ANOVAs were used to compare ethanol concentrationresponses or 2-hour drinking between groups ( Figure 4C and 5A) or concentration-responses between groups ( Figure 1A ). In the case of the ANOVAs, Tukey's post-hoc tests were used for multiple comparisons testing as appropriate.
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Results
The leak potassium channel KCNK13 is potentially involved in ethanol excitation in the VTA.
A number of conditions interfere with leak potassium channel function, including external quinine, quinidine, low external pH, temperature, volatile anesthetics like isoflurane (Enyedi and Czirjak, 2010; Goldstein et al., 2001) , and high external calcium ion (Ca ++ ) (Goldstein et al., 2001; Rajan et al., 2000) . We demonstrated previously that quinine (Nimitvilai et al., 2016) and quinidine (Appel et al., 2003) block ethanol excitation, pointing to the possibility that a specific leak potassium channel might underlie ethanol-induced excitation in the VTA. In initial experiments to try to identify the quinidine-sensitive target of alcohol, we increased the extracellular Ca ++ concentration, which blocked the ethanol-induced excitation ( Figure 1A ). Initial firing rate of neurons in this experiment was 1.9 ± 0.2 Hz with a CV of 0.15 ± 0.08. In the presence of high extracellular Ca ++ , ethanol produced a concentration-dependent decrease in firing. One possibility for this inhibition could be the effect of ethanol to increase the activity of inhibitory barium-sensitive potassium channels (McDaid et al., 2008; Okamoto et al., 2006) . In the absence of the excitatory action of ethanol, this inhibitory action of ethanol might become apparent (You et al., 2018) . As Ca ++ has a variety of membrane and intracellular effects (on protein kinase C and calcium calmodulin kinase, for example), extensive additional studies will be needed to determine the mechanism of the ethanol-induced inhibition in the presence of high Ca ++ .
As leak potassium channels are sensitive to volatile anesthetics, we tested the effect of isoflurane on neuronal firing. Initial firing rate of neurons in this experiment was 2.6 ± 0. of VTA neurons, as other leak channels are activated by volatile anesthetics. As KCNK12 is largely localized to the endoplasmic reticulum (Chatelain et al., 2013; Renigunta et al., 2014) , we focused our investigation of ethanol excitation and drinking behavior on KCNK13.
Despite an early report using in situ hybridization that indicated low expression of Kcnk13 mRNA in the VTA (Rajan et al., 2001) , our immunohistochemical examination of the VTA indicates that KCNK13 immunoreactivity is observed in VTA neurons ( Figure 2A ). Both TH+ and TH-VTA neurons demonstrated KCNK13 immunoreactivity, indicating that KCNK13
is not expressed solely in DA VTA neurons. The presence of these channels in the VTA reinforced the possibility that KCNK13 on VTA neurons may modulate their activity.
Kcnk13 mRNA is upregulated by acute ethanol exposure in the VTA
To determine whether ethanol can alter the expression of Kcnk13, we measured Kcnk13 mRNA levels by qPCR at two time points, one hour and four hours, after an acute injection of ethanol (3 g/kg, i.p.). We observed a significant increase in Kcnk13 mRNA levels in the VTA of the mice four hours, but not one hour, after ethanol treatment (unpaired t test, t = -2.25, p<0.05
for the 4 hour group, n=9 from 9 mice per group) ( Figure 2B ), indicating that Kcnk13 may be an ethanol-regulated gene or ethanol may interfere with the degradation of Kcnk13 mRNA.
Consistent with this observation, at the 4 h time point at which there is an increase in Kcnk13 mRNA levels in the VTA, there is also an increase in the potency of ethanol to excite VTA neurons (Supplementary Figure S2) . Although KCNK13 protein expression was decreased by only about 15%, ethanol excitation was reduced by close to 50% at each concentration ( Figure 4C ). These results demonstrate that reduction of Kcnk13 expression diminished the excitatory effect of ethanol, supporting the idea that KCNK13 contributes to ethanol excitation of VTA neurons.
Knockdown of
KCNK13 regulates binge-like ethanol consumption
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Since KCNK13 regulates ethanol-induced excitation of VTA neurons, we hypothesized that it may also play a role in ethanol drinking. To test this, we microinjected lentivirus expressing shKcnk13 or shScr into the VTA and measured binge-like ethanol consumption three weeks after injection using a two-bottle variation of the DID test (Rhodes et al., 2005) . Mice expressing shKcnk13 in the VTA drank more ethanol than controls during the two-hour sessions (two-way ANOVA, effect of shRNA, F 1, 84 =13.5, p<0.001) ( Figure 5A ), indicating an important role of KCNK13 in this model of binge alcohol drinking.
In contrast to the effect on drinking during two-hour drinking sessions, ethanol consumption during four-hour drinking sessions was not different between the groups (one-way ANOVA, F 3,28 = 1.42, p>0.05) ( Figure 5B ), possibly indicating a compensatory upregulation (see Discussion below). Blood ethanol levels achieved on the last day of drinking were 132.8 ± 16.5 mg % and 125.9 ± 21.3 mg%, in the mice that received lentivirus expressing shScr and shKcnk13
(unpaired t-test, t-statistic= -0.23, DF=14, p>0.05; n=16 total, 6 shScr and 10 shKcnk13), respectively, indicating that both groups of mice were achieving similar and pharmacologically relevant BECs ( Figure 5C ). The groups did not differ in ethanol preference ( Figure 5D ), possibly due to the overall high ethanol preference by both groups (i.e., a possible ceiling effect).
Knockdown of Kcnk13 had no significant effect on sucrose drinking ( Figure 5E ), indicating a selectivity of the effect of KCNK13 knockdown on ethanol intake. The similar sucrose intake between shScr and shKcnk13 groups also suggests that KCNK13 knockdown did not have a general effect on motor performance and that the effect on binge drinking did not generalize to all substances.
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Discussion
Using pharmacological, molecular and behavioral methods, our results support a significant role for KCNK13 channels in ethanol excitation of VTA neurons. This effect of ethanol on KCNK13 in the VTA is likely to be behaviorally relevant, as Kcnk13 knockdown in the VTA increased ethanol consumption. Ethanol excites DA neurons of the VTA in the absence of synaptic connections, indicating that ethanol-induced excitation is mediated by ethanolsensitive elements on the membrane of these neurons (Brodie et al., 1999) . Among those cellular elements (You et al., 2018) , KCNK13 channels should be considered as an important ethanolsensitive ion channel on VTA neurons.
A model of the role of KCNK13 channels on VTA neuronal activity is presented in Figure 6 . In general, flow of potassium ions through KCNK13 and other leak channels maintains a negative intracellular membrane potential, controlling the spontaneous firing rate and the steady-state level of neurotransmitters released onto the targets of these neurons ( Figure 6A ).
Ethanol blocks KCNK13 channels and reduces this potassium current, depolarizing the membrane and increasing the firing rate, resulting in an increase in neurotransmitter release onto the targets of VTA projections ( Figure 6B ). In the case of the shRNA experiments, reducing the number of KCNK13 channels shifts the ethanol concentration-response curve to the right, thus we would predict that this reduction would increase the amount of ethanol needed to produce an equivalent release of neurotransmitters, including dopamine, in VTA target regions.
Downregulation of Kcnk13 with shRNA did not result in a significant increase in baseline firing rate, possibly due to a compensatory upregulation of other, ethanol-insensitive leak potassium channels. Note the reduction of mRNA and protein for KCNK13 channels was relatively modest (~22% and ~15% repectively), and it is unknown what proportion of the overall leak channel M A N U S C R I P T
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14 population is comprised of KCNK13 channels. In our experiments, we confirmed that knockdown of Kcnk13 in the VTA reduced the ability of ethanol to excite VTA neurons and increased binge-like ethanol consumption. Together, these results support a role for KCNK13 in the VTA in alcohol intake, demonstrating that reducing KCNK13 decreases ethanol-induced excitation of VTA neurons and causes an increase in binge drinking.
Mice expressing shKcnk13 in the VTA drank more ethanol than control mice in the twohour sessions, indicating that KCNK13 plays an important role in regulating binge-like alcohol drinking. We hypothesize that due to a reduction of the alcohol-sensitive target KCNK13 in the VTA, more alcohol was required in the shKcnk13-expressing mice to reach the same level of VTA activation as shScr-expressing mice ( Figure 6 ). There was no effect of Kcnk13 knockdown on sucrose consumption, indicating that Kcnk13 is not generally involved in consumption of rewarding sweet solutions. We did not test for the effect of Kcnk13 knockdown on the consumption of a bitter solution such as quinine, therefore it is still a possibility that the increase in ethanol consumption in mice expressing shKcnk13 is due to decreased sensitivity to the bitter taste of ethanol.
Interestingly, we found that the amount of ethanol consumed, and the BECs achieved, after 4 hours of drinking were similar in mice expressing the Kcnk13 shRNA in the VTA and shScr controls. This result might be explained by an increase in Kcnk13 expression four hours after ethanol treatment, as demonstrated in Figure 2 . Upregulation of Kcnk13 over four hours could compensate for ethanol-induced inhibition of KCNK13, and overcome the modest (15-22%) knockdown by shKcnk13. A major additional study would be needed to accurately assess the time-course of changes in Kcnk13 mRNA and KCNK13 protein expression over a two-hour or four-hour drinking session, and over one to four days of DID. Alcohol intake over the two-
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15 hour sessions suggests the possibility that intrinsically lower levels of KCNK13 may be a risk factor for binge drinking. More extensive studies of the interaction of Kcnk13 expression with alcohol consumption, and the use of a conditional Kcnk13 knockout specifically in VTA neuronal subtypes, will be necessary to understand the specifics of dynamic changes in KCNK13
on VTA neurons that may drive binge drinking.
In addition to KCNK13, other neurotransmitters and ion channels are likely to play roles in the regulation of ethanol-induced excitation. We and others have demonstrated several actions of ethanol on VTA neurons, including reducing M-current (Koyama et al., 2007) , and increasing both h-current (Brodie and Appel, 1998; Okamoto et al., 2006 ) and a barium-sensitive potassium conductance (Herman et al., 2015; McDaid et al., 2008) ; these effects would alter the magnitude of ethanol excitation by affecting the passive electrical membrane properties of the neuron.
Increasing or decreasing the resistance of the membrane, for example, would make the cells more or less excited by ethanol action on KCNK13 channels. Likewise, the efficiency of KCNK13-mediated excitation could be altered by a variety of agents, including h-channel blockers (McDaid et al., 2008; Okamoto et al., 2006) , knockout of G protein-coupled potassium channels (Herman et al., 2015) , and pharmacological agents that affect cholinergic (Ericson et al., 2008; Larsson et al., 2002) , GABAergic (Steffensen et al., 2009; Theile et al., 2011) or glutamatergic (Steffensen et al., 2000) neurotransmission. Unlike these other agents, pharmacological conditions that block KCNK13 (e.g., quinine (Nimitvilai et al., 2016) , high extracellular Ca ++ (Figure 1) ), also reduce the excitatory effect of ethanol, suggesting that KCNK13 is a primary target of ethanol in the VTA. The results presented here indicate a novel and important role of KCNK13 in ethanol actions on VTA neurons.
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While both TH-immunopositive and -immunonegative cells expressed KCNK13, ethanol-induced excitation of neurons with electrophysiological characteristics of DA neurons was reduced by treatments that decreased expression of KCNK13, although as noted above, nondopamine neurons may have the same electrophysiological profile (Margolis et al., 2006) . The VTA contains primarily GABAergic and DA neurons; DA neurons are excited by ethanol (Brodie et al., 1990) , whereas ethanol inhibits GABAergic neurons (Gallegos et al., 1999) . We did not examine the response of neurons adhering to the electrophysiological profile for
GABAergic neurons, so we do not know whether there are additional membrane targets that might attenuate the excitatory effect of ethanol on KCNK13 on those GABAergic neurons. If KCNK13 channels play a significant role in regulating excitability of GABAergic neurons of the VTA, blockade of those channels by ethanol would be expected to excite the GABA neurons as well. Extensive studies with selective knockout models or upregulation of KCNK13 in GABAergic and DAergic neurons would be helpful in developing a better understanding the role of KCNK13 in the VTA.
Four hours of access to alcohol in the drinking in the dark paradigm resulted in blood ethanol concentrations of greater than 125 mg/dl (> 27 mM; Figure 5C ), while 0.08 g/dl (80 mg%, legal intoxication in many US states) is about 17 mM. One confound noted in the past has been that the concentrations of ethanol needed to activate DA-like VTA neurons in rodent brain slices (40-120 mM, but also see (Avegno et al., 2016; Mrejeru et al., 2015) ) are higher than those likely to be achieved during normal ethanol intake in humans, and are higher than ethanol concentrations that cause the increased dopamine release observed with in vivo microdialysis (Vena and Gonzales, 2015) or in vivo voltammetry (Jones et al., 2006; Signs et al., 1987) . This reduced ethanol potency in vitro may be partially explained by the loss of connections to VTA M A N U S C R I P T
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neurons from other brain areas that is a consequence of the brain slice method. However, Ungless et al. demonstrated a significant decrease in a leak potassium current after axotomy in Aplysia (Ungless et al., 2002) , although the specific leak channel in these experiments was not identified. Downregulation of leak potassium channels in response to axotomy has been established in mammalian tissue as well; TREK2 (Acosta et al., 2014) and TRASK (Tulleuda et al., 2011) are reduced after axotomy in rat nociceptors, for example. As axotomy is a normal consequence of in vitro neuronal preparations, it is possible that rapid downregulation of channels like KCNK13 occurs as a consequence of brain slice preparation, resulting in a decrease in the magnitude of ethanol excitation. Additional studies will be necessary to support this speculative hypothesis, but, if true, this would further support the role of KCNK13 in ethanol excitation, and, in addition, explain why ethanol is less potent in stimulating DA VTA neurons in vitro than in vivo.
Ethanol activation of neurons of the VTA was first observed in vivo (Gessa et al., 1985) and in vitro (Brodie et al., 1990) was microinjected into the mouse VTA. Three weeks after injection, mice were tested for bingelike alcohol drinking. Mice injected with shKcnk13 (n=10) drank significantly more during the two-hour drinking sessions than mice injected with shScr (n=6) (two-way ANOVA, effect of shRNA, F 1, 84 =13.5, p<0.001).
B. On day 4 and day 11 of the Drinking in the Dark protocol, mice were given access to ethanol solutions for 4 hours instead of 2 hours. There was no significant difference between the groups in the amount of ethanol consumed in 4 hours.
C. Blood ethanol concentrations were assessed after the four-hour drinking session on day 11.
No significant difference in blood alcohol levels between the groups was observed.
D. Ethanol preference (assessed during the drinking in the dark test), is calculated as the percent of ethanol consumed over total fluid consumption. There was no significant difference in ethanol preference, but as both groups preferred ethanol to a great extent (~80%), there may have been a ceiling effect; that is, as both the shKcnk13 (n=10) and the control (n=6) groups preferred ethanol to such a great extent, there was little room to distinguish between the groups (two-way RM ANOVA, F 1, 4 =0.811, p>0.05).
E. Following two weeks of ethanol drinking, mice that had received injections of either lentiviral-delivered Kcnk13 shRNA (shKcnk13, n=6) or scrambled control (shScr, n=6) were tested for sucrose consumption for four days, for two hours per day. There was no significant difference between the groups (two-way ANOVA, F 1, 40 =0.26, p>0.05). 
